Intra-cellular therapies investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of intra-cellular therapies, inc. - itci

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of intra-cellular therapies, inc. (nasdaqgs: itci) to johnson & johnson (nyse: jnj). under the terms of the proposed transaction, shareholders of intra-cellular will receive $132.00 in cash for each share of intra-cellular that they own. ksf is seeking to determine whether this consideration and the process t.
ITCI Ratings Summary
ITCI Quant Ranking